Literature DB >> 22695464

Prevalence of colorectal cancer screening among adults--Behavioral Risk Factor Surveillance System, United States, 2010.

Djenaba A Joseph1, Jessica B King, Jacqueline W Miller, Lisa C Richardson.   

Abstract

Among cancers that affect both men and women, colorectal cancer is the second leading cause of cancer death. In 2007 (the most recent year for which data are available), >142,000 persons received a diagnosis for colorectal cancer and >53,000 persons died. Screening for colorectal cancer has been demonstrated to be effective in reducing the incidence of and mortality from the disease. In 2008, the U.S. Preventive Services Task Force (USPSTF) recommended that persons aged 50-75 years at average risk for colorectal cancer be screened by using one or more of the following methods: high-sensitivity fecal occult blood testing (FOBT) every year, sigmoidoscopy every 5 years with FOBT every 3 years, or colonoscopy every 10 years.

Entities:  

Mesh:

Year:  2012        PMID: 22695464

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  98 in total

1.  Physician use of persuasion and colorectal cancer screening.

Authors:  Jennifer Elston Lafata; Tracy Wunderlich; Susan A Flocke; Nancy Oja-Tebbe; Karen E Dyer; Laura A Siminoff
Journal:  Transl Behav Med       Date:  2015-03       Impact factor: 3.046

2.  Evaluating an Electronic Measure of Colorectal Cancer Screening at Indian Health Service Facilities, 2008-2010.

Authors:  Diana Redwood; Anil Suryaprasad; Donald Haverkamp; Charlene Wong; Ellen Provost; David Espey
Journal:  IHS Prim Care Provid       Date:  2014-06

3.  Comparing 3 values clarification methods for colorectal cancer screening decision-making: a randomized trial in the US and Australia.

Authors:  Alison Brenner; Kirsten Howard; Carmen Lewis; Stacey Sheridan; Trisha Crutchfield; Sarah Hawley; Dan Reuland; Christine Kistler; Michael Pignone
Journal:  J Gen Intern Med       Date:  2013-11-23       Impact factor: 5.128

4.  Validation of self-reported colorectal cancer screening behaviors among Appalachian residents.

Authors:  Paul L Reiter; Mira L Katz; Jill M Oliveri; Gregory S Young; Adana A Llanos; Electra D Paskett
Journal:  Public Health Nurs       Date:  2013-04-05       Impact factor: 1.462

5.  Regional variation in colorectal cancer testing and geographic availability of care in a publicly insured population.

Authors:  Stephanie B Wheeler; Tzy-Mey Kuo; Ravi K Goyal; Anne-Marie Meyer; Kristen Hassmiller Lich; Emily M Gillen; Seth Tyree; Carmen L Lewis; Trisha M Crutchfield; Christa E Martens; Florence Tangka; Lisa C Richardson; Michael P Pignone
Journal:  Health Place       Date:  2014-07-24       Impact factor: 4.078

6.  Overuse of colonoscopy for colorectal cancer screening and surveillance.

Authors:  Gina R Kruse; Sami M Khan; Alan M Zaslavsky; John Z Ayanian; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2014-09-30       Impact factor: 5.128

7.  Assessing the effectiveness of a cancer screening test in the presence of another screening modality.

Authors:  Jessica Chubak; Rebecca A Hubbard; Eric Johnson; Aruna Kamineni; Carolyn M Rutter
Journal:  J Med Screen       Date:  2014-12-09       Impact factor: 2.136

8.  Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study.

Authors:  Chiranjeev Dash; Julie R Palmer; Deborah A Boggs; Lynn Rosenberg; Lucile L Adams-Campbell
Journal:  Am J Epidemiol       Date:  2013-10-02       Impact factor: 4.897

9.  Potential Biases Introduced by Conflating Screening and Diagnostic Testing in Colorectal Cancer Screening Surveillance.

Authors:  Elizabeth A Becker; Derek M Griffith; Brady T West; Nancy K Janz; Ken Resnicow; Arden M Morris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-21       Impact factor: 4.254

Review 10.  Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis.

Authors:  Thomas M Atkinson; Talya Salz; Kaitlin K Touza; Yuelin Li; Jennifer L Hay
Journal:  J Behav Med       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.